Materion (MTRN) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
26 Mar, 2026Executive summary
Annual meeting scheduled for May 7, 2026, with voting on director elections, auditor ratification, executive compensation, and a board size amendment.
Shareholders of record as of March 12, 2026, are eligible to vote; proxy materials are available online to reduce environmental impact.
Company emphasizes strong pay-for-performance philosophy, operational excellence, and alignment of executive compensation with shareholder interests.
2025 performance saw net sales of $1.79B, value-added sales of $1.05B, and net income of $74.8M.
Voting matters and shareholder proposals
Shareholders will vote to elect nine directors for one-year terms.
Ratification of Ernst & Young LLP as independent auditor for 2026 is on the agenda.
Advisory (non-binding) vote on named executive officer compensation (Say-on-Pay).
Proposal to amend Articles of Incorporation to reduce board size range from 9–18 to 7–15.
Shareholder proposals for the 2027 meeting must be received by November 26, 2026.
Board of directors and corporate governance
Board consists of nine nominees, with a majority being independent and diverse in gender and ethnicity.
Board practices include annual elections, majority voting policy, stock ownership requirements, and annual self-assessments.
Non-executive chairman leads independent director sessions and board communications.
Committees oversee audit, compensation, governance, and ESG matters.
Latest events from Materion
- Proxy covers director elections, auditor ratification, pay, board size, and ESG oversight.MTRN
Proxy Filing12 Mar 2026 - 2026 guidance targets 15% EPS growth and margin expansion, led by semiconductor and defense.MTRN
Q4 202512 Feb 2026 - Record Q2 sales, EBITDA, and EPS; aerospace and defense offset industrial softness.MTRN
Q2 20242 Feb 2026 - Record adjusted EBITDA margin achieved as net income fell; full-year EPS guided at $5.20–$5.40.MTRN
Q3 202417 Jan 2026 - Record adjusted EBITDA and margin expansion achieved, with 2025 guidance signaling continued growth.MTRN
Q4 202429 Dec 2025 - Record Q1 margin and earnings growth achieved, with tariff risks closely monitored.MTRN
Q1 202523 Dec 2025 - Proxy covers director elections, new equity plan, auditor ratification, and executive pay.MTRN
Proxy Filing2 Dec 2025 - Record adjusted EBITDA margin, strong cash flow, and robust growth drive positive Q2 2025 outlook.MTRN
Q2 202516 Nov 2025 - Q3 net income up 14% on record margins, strong orders, and a new $50M buyback program.MTRN
Q3 202530 Oct 2025